Advertisement Specific types of immune cells unleashed by cancer immunotherapy appear to cause myocarditis, an inflammatory ...

The heart tissue showed upregulation of molecular pathways that help recruit and retain immune cells involved in inflammation. Patients with active disease also had greater abundance of clusters of ...

PD-1 and PD-L1 immune checkpoint inhibitors (ICIs) for treating advanced cancer were associated with an increased risk of new ...

The process of identifying promising small molecule drug candidates that target cancer checkpoints may become faster and ...

在一项新的研究中，来自哥伦比亚大学的研究人员设计出了一种能教育免疫系统消灭癌细胞的益生菌，从而为利用细菌的天然肿瘤靶向特性研制新型癌症疫苗打开了大门。这种细菌癌症疫苗可以个性化地攻击每个人的原发肿瘤和转移灶，甚至可以预防未来的复发。相关研究结果于20 ...

Some patients being treated with immune checkpoint inhibitors, a type of cancer immunotherapy, develop a dangerous form of heart inflammation called myocarditis. Researchers led by physicians and ...

Led by Haydn T. Kissick, PhD, a researcher in the Cancer Immunology Research Program at Winship Cancer Institute and ...

A team of Rice University bioengineers has developed a mathematical model that clarifies why interleukin-12 (IL-12) ⎯ a potent immune-boosting protein that holds promise for cancer treatment ⎯ loses ...

The 22nd Annual Winter Lung Cancer Conference, January 31-February 2, 2025, will cover advances in NSCLC and SCLC treatment.

Pre-surgery treatment with the novel drug vidutolimod and the PD-1 checkpoint inhibitor nivolumab led to tumor control in 55% ...

Crescent Biopharma is advancing a drug its CEO claims is “purpose-built” to be a perfected version of Summit Therapeutics’ ...

The findings were published Oct. 16 in Nature in a paper titled "Probiotic neoantigen delivery vectors for precision cancer immunotherapy." The bacterial vaccine proved to be particularly more ...